Cargando…
A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome
BACKGROUND: The tissue factor (TF)-dependent extrinsic pathway has been suggested to be a central mechanism by which the coagulation cascade is locally activated in the lungs of patients with acute lung injury and acute respiratory distress syndrome (ALI/ARDS) and thus represents an attractive targe...
Autores principales: | Morris, Peter E, Steingrub, Jay S, Huang, Bee Y, Tang, Shamay, Liu, Patrick M, Rhode, Peter R, Wong, Hing C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299584/ https://www.ncbi.nlm.nih.gov/pubmed/22340260 http://dx.doi.org/10.1186/1471-2466-12-5 |
Ejemplares similares
-
Population Pharmacokinetics and Pharmacodynamics Modelling of Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome
por: Yang, Shuying, et al.
Publicado: (2016) -
Pneumonectomy subjects with acute respiratory distress syndrome: what to do
por: Unnikrishnan, Ramesh
Publicado: (2015) -
Acute Respiratory Distress
por: Maloy, James, et al.
Publicado: (2018) -
Acetylcholine receptor antagonists in acute respiratory distress syndrome: much more than muscle relaxants
por: Jansen, Diana, et al.
Publicado: (2018) -
The Association of Frailty With Long-Term Outcomes in Patients With Acute Respiratory Failure Treated With Noninvasive Ventilation
por: Stefan, Mihaela, et al.
Publicado: (2022)